[{"NetIncomeLoss_1_Q3_USD":-36043000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":30181000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":9732000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":51176884.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":54463412.0,"AccruedLiabilitiesCurrent_0_Q3_USD":32674000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q3_USD":21.5,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":39014000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":31700000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":8290000.0,"Depreciation_3_Q3_USD":9067000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":73981000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_3_Q3_shares":1816277.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":0.0,"AssetsCurrent_0_Q3_USD":310068000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":151230000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":-14000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":-15000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":161866000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":79022000.0,"Assets_0_Q3_USD":374380000.0,"UnrealizedGainLossOnInvestments_1_Q3_USD":-15000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":23.03,"StockGrantedDuringPeriodValueSharebasedCompensation_1_Q3_USD":82000.0,"Investments_0_Q3_USD":79022000.0,"Liabilities_0_Q3_USD":82795000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":44656000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":21.42,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":-654000.0,"PrepaidExpenseCurrent_0_Q3_USD":10632000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":5499000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":1238000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":92000.0,"AccountsReceivableNetCurrent_0_Q3_USD":18777000.0,"CommonStockValue_0_Q3_USD":562000.0,"Revenues_3_Q3_USD":52192000.0,"ShareBasedCompensation_3_Q3_USD":15419000.0,"Revenues_1_Q3_USD":18253000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":173240000.0,"CostsAndExpenses_3_Q3_USD":181082000.0,"CostsAndExpenses_1_Q3_USD":54388000.0,"IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_3_Q3_USD":137000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-127666000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-36058000.0,"OtherAssetsNoncurrent_0_Q3_USD":22889000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":201637000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":24651000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1060755000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_3_Q3_USD":12400000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":20.78,"TreasuryStockRetiredCostMethodAmount_1_Q3_USD":0.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":170494000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":7339217.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":4407713.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-769734000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":75165000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":6033000.0,"CommonStockSharesOutstanding_0_Q3_shares":56174932.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":7027237.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":3000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":5796000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-106365000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":387000.0,"LiabilitiesCurrent_0_Q3_USD":50121000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":201637000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":4500000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q3_USD":36973000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":-1615000.0,"AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0_Q3_USD":2000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":291585000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":448732.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":18806000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":41423000.0,"NetIncomeLoss_3_Q3_USD":-127652000.0,"AccountsPayableCurrent_0_Q3_USD":4380000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":150901000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":79019000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":5778000.0,"IncreaseDecreaseInOtherCurrentLiabilities_3_Q3_USD":2245000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.01,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":10.5,"CommonStockSharesAuthorized_0_Q3_shares":125000000.0,"OperatingIncomeLoss_3_Q3_USD":-128890000.0,"OperatingIncomeLoss_1_Q3_USD":-36135000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":3900000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":9259000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":14.97,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":2346000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":9.93,"AllocatedShareBasedCompensationExpense_3_Q3_USD":15419000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":5832000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":735322.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":3808000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":0.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-2.49,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.66,"OtherLiabilitiesNoncurrent_0_Q3_USD":2245000.0,"StockholdersEquity_0_Q3_USD":291585000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q3_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":374380000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-4816000.0,"Ticker":"MGNX","CIK":"1125345","name":"MACROGENICS INC","OfficialName":"MacroGenics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"504089511.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201104"}]